BTF Northwest Women’s Cancer Conference

Portland, OR US
September 17, 2022

The “BTF Northwest Women’s Cancer Conference” is a CME-accredited activity featuring experts in breast cancer and gynecologic malignancies. The goal of this activity is to improve the knowledge and competence of learners to apply practice-changing clinical data and expert recommendations to optimize clinical outcomes for patients with breast cancer and gynecologic malignancies. The program features in-depth discussion and analysis of the latest scientific findings and practice-changing advances in the field. Expert faculty will aim to place the role of different therapeutic agents in the clinical context and discuss how to utilize these therapeutic options to effectively contribute to patient care.

This women's cancer conference will augment healthcare providers’ foundation of knowledge and clinical competence in the management of women’s cancers.

Conference highlights:

  • Audience response system
  • Core competencies covered include patient care/patient-centered care, medical knowledge, system-based practice, and practice-based learning and improvement.
  • Opportunities to network with colleagues and interact with faculties
  • Program topics are clinically relevant and can immediately be applied to clinical practice.

 

Target Audience

  • Medical Oncologists
  • Surgical Oncologists
  • Radiation Oncologists
  • Gynecological Oncologists
  • Oncology Fellows
  • Oncology Nurses
  • Nurse Practitioners
  • Physician Assistants
  • Oncology Pharmacists

Learning Objectives

Upon successful completion of this educational activity, participants will be able to:

  • Discuss the study design and primary endpoints of recently reported and ongoing clinical trials evaluating novel strategies for the management of women’s cancers
  • Review frequent molecular abnormalities in women’s cancers, and appropriate timing of testing to detect these abnormalities.
  • Integrate emerging evidence in precision oncology into treatment paradigms for the treatment of women’s cancer.
  • Compare and contrast the safety and efficacy profiles of novel therapeutic strategies in the management of women’s cancers
Course summary
Available credit: 
  • 5.25 ABIM MOC II
    Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 5.25 Medical Knowledge points in the American Board of Medicine's (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider's responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.
  • 5.25 AMA PRA Category 1 Credit™
    The Binaytara Foundation is accredited by the Washington State Medical Association to provide continuing medical education for physicians. The Binaytara Foundation designates this live activity for a maximum of 5.25 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity. This activity meets the criteria for up to 5.25 hours of Category I CME credit to satisfy the relicensure requirements of the Washington State Medical Quality Assurance Commission.
  • 5.25 Nursing Contact Hours
    Provider approved by the California Board of Registered Nursing, Provider # CEP17035, for 5.25 Contact Hours.
Course opens: 
05/17/2022
Course expires: 
11/17/2022
Event starts: 
09/17/2022 - 7:00am PDT
Event ends: 
09/17/2022 - 3:00pm PDT
Cost:
$200.00
Add to calendar: 

07:00 AM - 08:00 AM: Breakfast/Registration/Exhibits

08:00 AM - 08:15 AM: Opening remarks

08:15 AM - 09:15 AM: SESSION 1: Loco-regional therapy in breast cancer

Moderator: Dr. Alexandra Zimmer

8:15 AM - 8.35 AM: Breast cancer surgery update - Dr. Laura Lazarus
8.35 AM - 8:55 AM: Breast cancer radiation oncology update - Dr. Kiri Cook
8:55 AM - 9:15 AM: Case-based discussion (1 case) - Dr. Angelena Crown

09:15 AM - 10:30 AM: SESSION 2: HER2- breast cancer

Moderator:  Dr. Alison Conlin
09:15 AM - 9:35 AM: Updates in the management of ER+/HER2- breast cancer - Dr. Evie Hobbs
09:35 AM - 9:55 AM: Systemic therapy strategies in triple-negative breast cancer - Dr. Sasha Stanton
09:55 AM - 10:30 AM: Case-based discussion (2 cases) - Dr. Vicky Lee and Dr. Wendy Wang

10:30 AM - 11:00 AM: Break & Exhibits

11:00 AM: - 12:15 PM: SESSION 3: HER2+ breast cancer and Precision Oncology

Moderator: Dr. Sara Matar
11:00 AM - 11:20 AM: New therapeutic strategies in HER2-positive breast cancer - Dr. Zahi Mitri
11:20 AM - 11:40 AM: Precision Oncology in breast cancer (Tumor-germline sequencing/CtDNA and other molecular guided therapies) - Dr. Siddhartha Yadav
11:40 AM - 12:15 AM: Case-based discussion (2 cases) - Dr. Nora Bucher and Dr. Bo Wang

12:15 PM - 01:15 PM:  Lunch & Exhibits 

12:15 PM to 1:00 PM: “A Treatment Option For Patients with Her2+ Metastatic Breast Cancer (MBC)” – with Chelsea Gawryletz, DO, in Broadway/Weidler breakout room

Sponsored by Seagen.

This talk is not part of the CME activity.

01:15 PM - 3:00 PM: SESSION 4: Gynecological Cancer Session

Moderator: Dr. Tanja Pejovic 
01:15 PM - 01:35 PM Ovarian cancer update - Dr. Dan Veljovich
01:35 PM - 01:55 PM Uterine cancer, Cervical cancer update - Dr. Kalyan Banda
01:55 PM - 02:15 PM Gynecologic cancer radiation oncology update - Dr. Jenna Kahn
02:15 PM - 03:00 PM Case-based discussion (3 cases) - Dr. Zheng Wu, Dr. Selina Liu, and Lisa Egan, PA-C

3:00 PM Adjourn

DoubleTree by Hilton
1000 NE Multnomah St
Portland, OR 97232
United States

A limited number of rooms have been reserved for the attendees of this conference at the DoubleTree by Hilton, Portland at the discounted rate of $159 per night. Please call 503-281-6111 to book a room.

Reservation deadline: August 7, 2022

Book your hotel room here.

 

 

Travel

The Doubletree by Hilton Portland has the largest on-site parking structure in the city; attendees will appreciate the
the convenience of parking on-site in an affordable, secure garage. The current rate is as follows (subject to change):

  • Overnight parking with in-and-out privileges is $27 per night
  • Day parking is $5.50 per hour with a maximum of $27 per day

The Doubletree by Hilton Portland is 9 miles away from the Portland International Airport.

Light Rail Service - There is a Light Rail from the airport to downtown that stops a block from the DoubleTree by Hilton. One way adult fare is $2.50.

IDENTIFICATION AND MITIGATION OF POTENTIAL CONFLICT OF INTERESTS:

All conflict of interest has been identified and mitigated for individuals in control of contents.

PLANNING COMMITTEE DISCLOSURE STATEMENT:

None of the members of the planning committee, nor any member of their immediate families, have a relevant financial interest in or affiliation with any commercial supporter of this educational activity and/or with the manufacturer(s) of commercial products and/or providers of any commercial services discussed in this educational activity.

Speaker/Topic Presenter(s)

Kalyan Banda

has a financial relationship (Other) with MorphoSys;.
has a financial relationship (Other) with Eli Lily ;.

Nora Bucher, MD

has no relevant financial relationships to disclose at this time.

Kiri Cook, MD

has no relevant financial relationships to disclose at this time.

Angelena Crown, MD

has no relevant financial relationships to disclose at this time.

Lis Egan

has no relevant financial relationships to disclose at this time.

Evthokia Hobbs, MD

has no relevant financial relationships to disclose at this time.

Jenna Kahn

has no relevant financial relationships to disclose at this time.

Laura Lazarus, MD, FACS

has no relevant financial relationships to disclose at this time.

Vicky Lee, MD PHD

has no relevant financial relationships to disclose at this time.

Qiuying (Selina) Liu, MD

has no relevant financial relationships to disclose at this time.

Zahi Mitri, MD, MS

has a financial relationship (Other) with Gilead;.
has a financial relationship (Other) with AstraZeneca;.
has a financial relationship (Other) with Daischi Sankyo;.

Sasha Stanton, MD PhD

has a financial relationship (Professional Services) with Stanford Prebys Burnham;.
has a financial relationship (Grant Or Contract) with IMV Inc;.

Dan Veljovich, MD

has a financial relationship (Independent contractor) with GSK;.
has a financial relationship (Independent contractor) with Merck;.
has a financial relationship (Independent contractor) with Eisai;.
has a financial relationship (Independent contractor) with AstraZeneca;.

Bo Wang, Bo Wang, MD

has a financial relationship (Independent contractor) with EMD Sorono;.
has a financial relationship (Independent contractor) with Astra Zeneca;.
has a financial relationship (Independent contractor) with Sanofi Genzyme;.
has a financial relationship (Independent contractor) with Pfizer;.
has a financial relationship (Independent contractor) with Guardant ;.

Xiaowen Wang, MD, PhD

has no relevant financial relationships to disclose at this time.

Zheng Wu, MD, PhD

has no relevant financial relationships to disclose at this time.

Siddhartha Yadav, Siddhartha Yadav, MD, FACP

has no relevant financial relationships to disclose at this time.
Moderator(s)

Alison Conlin, Md, Mph

has no relevant financial relationships to disclose at this time.

Sara Matar, MD

has no relevant financial relationships to disclose at this time.

Tanja Pejovic, MD, PhD

has no relevant financial relationships to disclose at this time.

Alexandra Zimmer

has no relevant financial relationships to disclose at this time.
Planning committee(s)

Siddhartha Yadav, Siddhartha Yadav, MD, FACP

has no relevant financial relationships to disclose at this time.

Fengting Yan, MD

has no relevant financial relationships to disclose at this time.

ACKNOWLEDGMENT OF COMMERCIAL SUPPORT

This activity is supported with independent medical education grants from the following companies:

  • Seagen, Inc.
  • Gilead Sciences, Inc.

Available Credit

  • 5.25 ABIM MOC II
    Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 5.25 Medical Knowledge points in the American Board of Medicine's (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider's responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.
  • 5.25 AMA PRA Category 1 Credit™
    The Binaytara Foundation is accredited by the Washington State Medical Association to provide continuing medical education for physicians. The Binaytara Foundation designates this live activity for a maximum of 5.25 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity. This activity meets the criteria for up to 5.25 hours of Category I CME credit to satisfy the relicensure requirements of the Washington State Medical Quality Assurance Commission.
  • 5.25 Nursing Contact Hours
    Provider approved by the California Board of Registered Nursing, Provider # CEP17035, for 5.25 Contact Hours.

If you are interested in exhibiting at this meeting, please visit our exhibit page here - https://education.binayfoundation.org/exhibit-information

Price

Cost:
$200.00
Please login or register to take this course.

Early-bird registration ends September 1st, 2022.

REGISTRATION FEES 

Physicians (non-industry) - $200

Non-physician HCP (non-industry) - $75

Industry representatives - $850

NOTICE TO HCPS EMPLOYED BY THE INDUSTRY:

If you are employed by industry, including pharmaceuticals and biotech companies, you must pay the INDUSTRY REGISTRATION FEE to participate in any meeting organized by the Binaytara Foundation. If you misrepresented yourself as a healthcare provider not employed by the industry and failed to pay the Industry registration fee, the following fees apply:

  • If your company has purchased a display table at the event, you will be billed the full INDUSTRY REGISTRATION FEE plus a fine equivalent to the full industry registration fee for that event = 2 X the industry registration fee.
  • If your company has NOT purchased a display table at the event AND you attended the meeting without paying a full industry registration fee, you will be billed a full GENERAL DISPLAY FEE for that event. 

Any outstanding display fee, registration fee, and fines must be paid before the industry employee or the company will be able to attend/display at our conferences again.

CANCELLATION POLICY

You may cancel your enrollment at any time. Cancellation fees apply as below:

  • 50% of the paid registration fee will be refunded if registration is cancelled six weeks before the conference.
  • No refunds will be issued if registration is cancelled after that date.  

No credits will be offered if you do not complete all required steps of this activity which include registration, participation in the live activity, and completion of pre & post tests as well as course evaluations.